1Tolleson TR,Newby LK,Harrington RA,et al. Frequency of stent thrombosis after acute coronary syndromes ( horn the SYMPHONY and 2nd SYMPHONY trials) [J]. Am J Cardio1,2003 ,92 :330-333.
2Muller I, Besta F, Schulz C, et al. Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement [ J ]. Thromb Haemost ,2003,89:783-787.
3Matetzky S,Shenkman B,Guetta V,et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombofic events in patients with acute myocardial infarction [ J]. Circulation ,2004,109:3171-3175.
4Wiviott SD,Antman EM. Clopidogrel resistance:a new chapter in a fast-moving story[J]. Circulation, 2004,109 : 3064-3067.
5Nguyen TA, Diodati JG, Pharand C,et al. Resistance to clopidogrel:a review of the evidence[ J] .J Am Coll Cardiol,2005,1945 (8) :1157-1164.
6Lau WC ,Gurbel PA,Watkins PB,et al. Contribution of hepatic eytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [ J]. Circulation ,2004,109 : 166-171.
7Gurbel PA,Bliden KP,Hiatt BL,et al. Clopidogrel for coronary stenting response variability ,drug resistance,and the effect of pretreatment platelet reactivity [ J]. Circulation ,2003,107:2908-2913.
8Wenaweser P, Dorffler Melly J, Imhoden K, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy [J]. J Am Coll Cardiol,2005, 745 ( 11 ) :1748-1752.
9Schumann A,Wiesenburg A ,Bueha E,et al. Platelet Adhesion Assay ( PADA), a new quantitative test for assessment of platdet function and the apeufie drug monitoring of GP Ⅱ b / Ⅲ a and ADP receptor antagonists [ J ]. Hamostaseologie, 2004,24 (3) :211-216.
10Lepantalo A,Virtanen KS,Heikkila J, et al. Limited early antiplatelet effect of 300mg elopidogrel in patients with aspirin therapy undergoing pereutaneous coronary interventions[J]. Eur Heart J,2004,25 (6) :476-483.
